Infinity Pharmaceuticals, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 32 rows in 2014. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-12-15: Reporting owner Palombella Vito J.; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-11-26: Reporting owner Palombella Vito J.; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-10-03: Reporting owner EVNIN ANTHONY B; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-10-03: Reporting owner EVNIN ANTHONY B; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-12-15 | Palombella Vito J. Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,737 0 owned after | $2.04 exercise price | 2014-12-16 | |
| 2014-11-26 | Palombella Vito J. Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,736 0 owned after | $2.04 exercise price | 2014-11-28 | |
| 2014-10-03 | EVNIN ANTHONY B Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,000 0 owned after | $12.94 exercise price | 2014-10-06 | |
| 2014-10-03 | EVNIN ANTHONY B Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 0 owned after | $12.94 exercise price | 2014-10-06 | |
| 2014-10-03 | EVNIN ANTHONY B Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 7,500 owned after | $11.85 exercise price | 2014-10-06 | |
| 2014-10-03 | EVNIN ANTHONY B Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 1,000 owned after | $11.85 exercise price | 2014-10-06 | |
| 2014-09-03 | Palombella Vito J. Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,105 0 owned after | $2.04 exercise price | 2014-09-05 | |
| 2014-09-03 | Palombella Vito J. Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,367 0 owned after | $2.04 exercise price | 2014-09-05 | |
| 2014-06-17 | EVNIN ANTHONY B Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $11.85 exercise price | 2014-06-19 | |
| 2014-06-17 | EVNIN ANTHONY B Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,000 2,000 owned after | $11.85 exercise price | 2014-06-19 | |
| 2014-06-17 | Fyfe Gwen A. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $11.85 exercise price | 2014-06-19 | |
| 2014-06-17 | VENUTI MICHAEL C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $11.85 exercise price | 2014-06-19 | |
| 2014-06-17 | VENUTI MICHAEL C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,000 4,000 owned after | $11.85 exercise price | 2014-06-19 | |
| 2014-06-17 | LANDER ERIC S Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $11.85 exercise price | 2014-06-19 | |
| 2014-06-17 | SELBY NORMAN C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $11.85 exercise price | 2014-06-19 | |
| 2014-06-17 | SELBY NORMAN C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $11.85 exercise price | 2014-06-19 | |
| 2014-06-17 | SELBY NORMAN C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,000 2,000 owned after | $11.85 exercise price | 2014-06-19 | |
| 2014-06-17 | SMITH IAN F Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $11.85 exercise price | 2014-06-19 | |
| 2014-06-17 | SMITH IAN F Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,000 4,000 owned after | $11.85 exercise price | 2014-06-19 | |
| 2014-03-06 | Berkowitz Jeffrey Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $14.29 exercise price | 2014-03-10 | |
| 2014-03-06 | SELBY NORMAN C Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 2,500 owned after | $8.87 exercise price | 2014-03-10 | |
| 2014-03-06 | Baselga Jose Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $14.29 exercise price | 2014-03-10 | |
| 2014-02-25 | Palombella Vito J. Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,736 0 owned after | $2.04 exercise price | 2014-02-27 | |
| 2014-02-07 holding as of filing | Roth David Officer (Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $20.78 exercise price | 2014-02-07 | ||
| 2014-02-07 holding as of filing | Roth David Officer (Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $20.78 exercise price | 2014-02-07 | ||
| 2014-02-07 holding as of filing | Roth David Officer (Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $12.91 exercise price | 2014-02-07 | ||
| 2014-02-07 holding as of filing | Roth David Officer (Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $13.62 exercise price | 2014-02-07 | ||
| 2014-01-10 | Santabarbara Pedro Officer (Chief Medical Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,600 16,600 owned after | $12.91 exercise price | 2014-01-14 | |
| 2014-01-10 | BLOCH LAWRENCE E Officer (EVP, CFO & CBO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +32,200 32,200 owned after | $12.91 exercise price | 2014-01-14 | |
| 2014-01-10 | Perkins Adelene Q Director, Officer (Pres & Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +85,500 85,500 owned after | $12.91 exercise price | 2014-01-14 | |
| 2014-01-10 | ADAMS JULIAN Officer (President of R&D) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +56,900 56,900 owned after | $12.91 exercise price | 2014-01-14 | |
| 2014-01-10 | Palombella Vito J. Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +32,200 32,200 owned after | $12.91 exercise price | 2014-01-14 |